American Express (AXP) Offering Possible 15.87% Return Over the Next 34 Calendar Days

American Express's most recent trend suggests a bullish bias. One trading opportunity on American Express is a Bull Put Spread using a strike $115.00 short put and a strike $105.00 long put offers a potential 15.87% return on risk over the next 34 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $115.00 by expiration. The full premium credit of $1.37 would be kept by the premium seller. The risk of $8.63 would be incurred if the stock dropped below the $105.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for American Express is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for American Express is bullish.

The RSI indicator is at 69.8 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for American Express

Collection Sites Achieves Expansion into State of Pennsylvania with Launch of 5 New COVID-19 Testing Sites; Appoints New Director Dr. Beverley Richardson
Thu, 14 Jan 2021 17:21:00 +0000
The continued success of Collection Sites rollout has led to the expansion into Pennsylvania, with 5 sites now operating across the state for a total of 40 operating sites. TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:34C1) is pleased to announce the launch of five new COVID-19 testing centres in Pennsylvania by its wholly owned subsidiary, Collection Sites, LLC. With individual sites currently achieving strong sales with 7-day rolling average of 75 tests per day and average test price exceeding US$95 per test, these five sites are expected to add substantively to Medivolve’s top-line revenue.In order to maximize operational efficiency, Collection Sites is conducting a state by state expansion where possible. The Pennsylvania sites are currently located on the properties of Simon’s Property Group, an investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company. With a population of over 12.9 million Americans, Pennsylvania was selected to serve as another important state for Collection Sites.“As Collection Sites continues to expand across the nation, we will look to build out a strong presence in high-population regions to better leverage our local infrastructure and minimize the cost of our operations,” says Mr. Tim Shelburn, President of Collection Sites. “As the awareness and marketing initiatives increase for our Pennsylvania locations we expect to see an increase in demand for our services and are proud to be able to provide important COVID-19 testing services to those seeking them in the state.”About Dr. Beverley Richardson Medivolve is also pleased to announce that Dr. Beverly Richardson has joined QuestCap’s Board of Directors. She will act as an independent director and is replacing outgoing Director Danny Callow. Dr. Beverley J. Richardson is a renowned psychotherapeutic practitioner whose collaborative efforts and clinical influence are reflected in some of the most compelling and effective addiction and behavioural health programs in North America which include: Sierra Tucson (Arizona), the Meadows (Arizona) and Betty Ford Centre (California).She has a Doctorate Degree in Psychology and is a B.C. Registered Clinical Counsellor, Internationally Certified Eating Disorder Specialist, and EMDR Level II Trauma Therapist. Dr. Richardson has integrated her extensive experience in health and wellness with her entrepreneurial spirit to form her nutraceutical and bioscience research and development enterprises.About the Collection Sites The pop-up labs will be managed by Las Vegas based company Collection Sites, LLC and powered by Alcala Testing and Analysis Services, a CLIA-licensed laboratory based in San Diego, California. Appointments and payments will be handled through an online portal key to flattening the curve is to increase testing.The testing centers will offer convenient access to rapid antibody and antigen (pending availability) tests – which take 8-10 minutes to administer and provide results within 24 hours. The sites also offer regular RT-PCR.  All tests can be administered with insurance coverage options. The tests results can be communicated via text or email and can be accompanied with a certificate of good health via a HIPAA-compliant smartphone application.For more information about the pop-up lab, the available sites and services visit Medivolve Inc.Medivolve Inc. (NEO:MEDV; OTC:COPRF; FRA:34C1)  seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. Specifically, Medivolve offers investors a diversified investment in the COVID-19 medical space across three areas; prevention, detection, and treatment.Medivolve has a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopaedic treatment, foot and ankle care, and sports medicine.Medivolve’s primary focus is to provide convenient and assessable medical services for testing of the COVID-19 virus to help combat the pandemic. This is achieved largely through two acquisitions: 100% of Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection Sites is setting up a series of COVID-19 testing sites across the United States with appointments and payments will be handled through the online portal Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution.For additional information, please contact:Doug Sommerville, CEO Doug.Sommerville@questcapinc.comFor investing inquiries please contact: Evan Veryard Evan.veryard@questcapinc.comFor US media enquires please contact: Veronica Welch +1-508-643-8000Cautionary Note Regarding Forward-looking InformationThis press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the expansion of COVID-19 testing sites; the proposed roll-out of testing sites; projected timelines for testing results; projected revenues from the testing; the pursuit by Medivolve of investment opportunities; and the merits or potential returns of any such investments. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Stocks to Gain From Small Business Shift to Digitization
Thu, 14 Jan 2021 15:15:03 +0000
Companies in the payments ecosystem serving small businesses are poised to gain from their increasing inclination toward business digitization.

Is Visa Stock A Buy Right Now After Plaid Deal Scrapped?
Wed, 13 Jan 2021 18:57:57 +0000
Visa has a strong earnings track record and is making more moves in digital payments. Is the stock a buy right now?

AmEx, Citi Dangle Bevy of Perks to Antsy Premium Card Customers
Wed, 13 Jan 2021 13:00:01 +0000
(Bloomberg) — Hundreds of dollars in statement credits. Extra points for ordering takeout. Cash back on virtual personal-training sessions.In the pandemic age, banks are getting creative in a bid to keep affluent customers. For years, these consumers flocked to premium credit cards, paying fees of around $500 a year in exchange for special access to airport lounges, extra rewards for travel and restaurant spending, and other perks. After months of being grounded, and the pandemic likely to drag on for much of 2021, many consumers are growing antsy.“Now we have a lot of home expenses because we’re all home — all the delivery services and the grocery shopping online,” said Bonnie Crawford, a software executive in Portland, Oregon, who’s had her Platinum card from American Express Co. for more than a decade. “You’re not getting extra points for shopping on Instacart or doing delivery services. So that really started me down the path of maybe this is the year I actually switch.”Crawford — who’s logged a million miles of air travel, and who normally flies at least 150,000 miles a year — said she phoned AmEx with her concerns and was offered a $500 statement credit to keep her $550-a-year card. Instead, she asked for 50,000 points, which she said she could redeem for rewards worth about $1,000.Banks are in a bind. Many have spent years building out their high-end card offerings with pricey sign-up bonuses and other perks. Take JPMorgan Chase & Co., for instance. When the company debuted its Sapphire Reserve card in late 2016, with 100,000 in points offered as a sign-up bonus, analysts estimated it wouldn’t break even on the investment for 5 1/2 years.‘Best Customers’“In general, you don’t become profitable to a credit-card company until several years after you get it,” Brian Kelly, founder and chief executive officer of the Points Guy website, which is dedicated to loyalty programs and credit cards. “The credit-card companies, in general, don’t want to lose their best customers. They pay a lot of money to acquire customers, whether that’s advertising, expensive mailers, all the sign-up bonuses.”In online forums, customers are swapping stories of the success — or lack thereof — they’ve had in getting retention offers when they’ve called to cancel or downgrade pricey cards. Some Sapphire Reserve customers, for instance, say they’ve received statement credits of as much as $250.But in general, hefty retention offers are only made to select customers, and banks don’t disclose their rationale for giving them out.Even so, JPMorgan said for now it’s now allowing Sapphire Reserve customers who normally have to use a $300 statement credit for travel to spend it at gas stations and supermarkets instead and is offering extra points for grocery-store purchases. The bank has also put a planned $100 annual-fee increase — which would have have boosted the cost to $550 a year — on hold for existing customers.Citigroup Inc. said it’s also temporarily allowing those who have the bank’s $495-a-year Prestige card to use their $250 annual travel credit at supermarkets and restaurants. The world’s largest credit-card issuer also gave a $225 credit to customers who had Citigroup’s American Airlines Group Inc. $450-a-year Executive card as of March.Souring LoansThe extra investment comes at a tough time for card lenders, who had to set aside extra provisions to cover souring loans last year as the pandemic drove up unemployment. That’s pinched the overall profitability of their card portfolios.Still, the companies’ efforts to keep customers seem to be working so far. Attrition levels haven’t begun to tick up for premium cards at JPMorgan, Citigroup and AmEx. And consumers paid about $13 billion in annual credit-card fees last year, the same amount as in 2019, according to consultancy R.K. Hammer.For AmEx, Covid-19 has forced the card giant to temporarily shift its longtime focus on travel and dining. Last year, for instance, the firm offered Platinum customers as much as $320 in statement credits for spending on select streaming and wireless-telephone services.This month, the lender unveiled new temporary perks tied to rewarding customers’ increased reliance on online shopping, including as much as $650 for virtual personal-training sessions from the luxury-gym chain Equinox, and $150 back for the food-delivery service Home Chef.‘Essential Categories’“For many years our focus has been on driving long term card member loyalty by regularly evolving our card offers and benefits,” Rachel Stocks, executive vice president of global premium products and benefits at AmEx, said in an emailed statement. “The offers we’ve introduced over the past year in at-home essential categories like streaming, wireless, grocery, e-commerce, business essentials and more are a continuation of this strategy.”Crawford, the AmEx customer who took extra points to keep her Platinum card, said she appreciates some of the newer offers, such as the credits for streaming services, saying they “took the sting” out of the fact she couldn’t use many other perks.“I do want to give AmEx credit,” she said. “They pivoted really well.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

American Express halts donations to lawmakers who opposed Biden certification
Mon, 11 Jan 2021 15:43:48 +0000
American Express said Monday it will join other major companies including Marriott in suspending donations to lawmakers who did not support the certification of President-elect Joe Biden's win last week. Amex Chairman and Chief Executive Officer Stephen J. Squeri said in a statement that “last week’s attempts by some congressional members to subvert the presidential election results and disrupt the peaceful transition of power do not align with our” values and said its political action committee will not support them. American Express said it has not contributed to senators who backed Electoral College objections, but previously made contributions to 22 of the 139 House members who voted for the objections.

Related Posts


MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.